Sign in

CIK 0001638097

  • Non-accelerated filer
  • Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 25327151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chief Financial Officer bought 56,580 shares at an average $0.53 ($29,847)
  5. 4 Open-market buy Director bought 50,000 shares at an average $0.57 ($28,460)
  6. 4 Open-market buy Director bought 30,000 shares at $0.53 ($15,900)
  7. 4 Open-market buy Chief Executive Officer bought 50,000 shares at $0.53 ($26,585)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3/A Insider 3/A
  12. 4/A Insider Changes in Ownership
  13. 4 Open-market buy Director bought 14,900 shares at $1.64 ($24,406)
  14. 4 Open-market buy Director bought 19,491 shares at $1.68 ($32,803)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 10,000 shares at $2.74 ($27,378)
  18. 4 Open-market buy U.S.based CFO bought 10,000 shares at $2.44 ($24,364)
  19. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.85 ($28,500)
  20. 4 Open-market buy President of R&D bought 10,000 shares at $2.53 ($25,250)

Page 5 of 7 · 126 filings